Docstoc

Conservative Surgery to Preserve Fertility in Gynaecological Cancers.ppt

Document Sample
Conservative Surgery to Preserve Fertility in Gynaecological Cancers.ppt Powered By Docstoc
					 Conservative Surgery to Preserve
Fertility in Gynaecological Cancers.

             Sean Kehoe
  Oxford Gynaecological Cancer Centre
           Churchill Hospital
               Oxford
             Malignancies
n   Cervical
n   Endometrial
n   Ovarian
n   Vulval Cancer ?
              Counselling
n   Counselling is very important

n   Often we are deviating from what
    could be considered the ‘Standard
    Recommendations’

n   In essence – experimentation with
    the patient taking the risk.
    Cervical Carcinoma


Occurs not uncommonly in younger patients [33% < 40 years]

A real increase in adenocarcinomas

An impression of more cases occurring in nulliparous women –
probably due to women delaying pregnancies as compared to
previous times.
About 33% of cervical carcinomas occur in women <40 years
         Cervical Carcinoma
n   Severe Dyskaryosis ? Invasion

n   ? Invasion on Colposcopy

n   Requires some form of biopsy
Stage 1A1 – Squamous Carcinoma

 A loop cone excision of the cervix is sufficient treatment




 Once all pre-invasive and invasive disease cleared.
Stage 1A1 Adenocarcinoma



Problem with ‘definition’

Now staging as 1A1 is acceptable


Skip lesions can occur : ? Just Pre-invasive

For lesions 3 -5 mm x 7 mm, 141 women – only 1 case of
lymph node disease [0.73%]
           Cervical Cancer:
            Trachelectomy
n   Rules
n   Nulliparous [?] – family incomplete
n   Careful clinical staging
n   MRI scan to evaluate tumour extent.
n   Ib1 [2cms] or less.
n   Adenocarcinomas ?
n   ? Poorly Differentiated
n   ?Lymph Vascular Space Invasion
    Trachelectomy



                           Excise to
                           Isthmus




Insert Cervical Circlage
                   Cervical Cancer
                                                  Cervical
                                                  Circlage




                                        Parametrial Tissue

But will surgery be further modified?
Why parametrial tissue which addresses only 2 of 4 planes ?

In tumour <10mm invasion and <2cms diameter – incidence of
parametrial involvement is estimates at 0.6%
Cervical Cancer



               Single or 2 stage procedure ?
      If single – depending on Frozen Section Histology



   Extra-peritoneal or Intra-peritoneal Lymphadenectomy?

If the procedure is about preserving fertility – it seems
logical to prevent intra-peritoneal surgery when an alternative is available.
Patients and tumor characteristics for the seven clinical studies of radical vaginal
                                 trachelectomy




    Beiner ME and Covens A (2007) Surgery Insight: radical vaginal trachelectomy as a method of fertility
         preservation for cervical cancer Nat Clin Pract Oncol 4: 353–361 doi:10.1038/ncponc0822
Table 2 Operative data and complications in the seven clinical studies of radical
                            vaginal trachelectomy




      Beiner ME and Covens A (2007) Surgery Insight: radical vaginal trachelectomy as a method of fertility
           preservation for cervical cancer Nat Clin Pract Oncol 4: 353–361 doi:10.1038/ncponc0822
Table 7 Number of obstetric outcomes in patients who underwent trachelectomy




     Beiner ME and Covens A (2007) Surgery Insight: radical vaginal trachelectomy as a method of fertility
          preservation for cervical cancer Nat Clin Pract Oncol 4: 353–361 doi:10.1038/ncponc0822
           Counselling
n Pregnancy:
If achieved –
         30% miscarriage rate
         Assume – Premature delivery
         Assume – Operative Delivery
Recurrence Rates




To date the recurrence rates at about 4% are not in excess of that expected
with a radical hysterectomy.

The application of this procedure to large tumours is less frequent now.
     How Safe: Trachelectomy?
n   Case selection very important
n   Probably as safe as Radical
    Procedures
n   Avoid in Large tumours [>2cms ?]
n   Avoid in rare/high risk tumours
n   For nulliparous women only?
ENDOMETRIAL CANCER
         Endometrial Cancer
A Rare issue in women where fertility
 is a factor.

n   Histopathology
n   Imaging
Both of these are paramount in decision
 making.
          Endometrial Cancer
n   Histology: Differentiation between Atypical
    Hyperplasia and Frank Carcinoma

n   Remember – when tissue confirms
    Atypical Hyperplasia – Frank Malignancy is
    found in the Hysterectomy specimen in
    40-50% of cases [Cancer 2006,GOG
    study]

n   Most would agree that fertility
    preservation should be limited to those
    with well differentiated tumours [stage
    1A]
       Endometrial Cancer
n Imaging:
This is important for the ‘staging’
  process.
CT/MTI/Ultrasound?
Kinkel et al,Radiology 1999: Meta-
  analysis
Contrast enhanced MRI best – BUT of
  note myometrial invasion detected
  correctly in 90% of cases – i.e. 10%
  false negative rate.
            Endometrial Cancer

In the main – progestagens used as therapy.

Treatment time to regression ranges from 3.5 – 9 months

Recurrence occurs in about 20% of responders

This approach requires careful surveillance – and repeated
endometrial curettage.
               Endometrial Cancer
n   How to manage??

                      Mirena IUCD

                      Progestogens:

                      GnRH analogues

       All the above have been used with reasonable success
                       [responses about 70%].

    Tamoxifen can increase the PR, and hence potentially enhance
                the efficacy of progestagenic agents
        Endometrial Cancer
                    Stage 1a
Treatment
              Curettage at 3/12
                                              Intervene
              Curettage at 6/12                   If
                                                 Any
                                              concerns
            If -                If +


        Attempt                   Offer
        pregnancy              Hysterectomy
            Endometrial Cancer
Ref             Cases   Response   Pregnancies

Kaku 2001       12      75%        2

Imai 2001       15      50%        2

Randall 1997    14      75%        ?

Gotlieb 2003    13      100%       9 babies

Signorelli, 2009 21     57%        13 pregnancies

Laurelli 2011   14      90%        1 baby

Miniq, 2011     14      57%        11 pregnancies
              Endometrial Cancer
n   Ushijima et al. J. Clinical Oncology 2007
n   28 Stage 1 A, 17 Atypical hyperplasia, all < 40 years

n   600mgs MPA with low dose aspirin

n   Continued for 28 weeks once responding
n   Endometrium checked 8 and 16 weeks

n   CR 55% Endometrial CA, and 82% AH

n   In responders– either oestrogen/progesterone therapy or Fertility
    therapy.

n   36 months follow-up – 12 pregnancies and 7 deliveries

n   However 47% recurrence rate – need careful monitoring
Distribution of clinicopathological characteristics in the endometrial cancer patients with conception in
the meta-analysis
Characteristics                   Patients no.             Group 1               Group 2               p

Age at diagnosis, yr (mean SD)             50                             32.8 , 4.1 (n = 14)            29.5, 5.3 (n = 36)            0.05
Age at pregnancy, yr (mean SD)             43                             34.3, 4.0 (n = 13)             30.9 , 5.3 (n = 30)           0.05
Histology type                             45                             14                             31                            1.0
Adenocarcinoma                             44                             14                             30
Adenosquamous                                1                             0                              1
Grade of differentiation                   41                             14                             27                            1.0
Well                                       38                             13                             25
Moderate and poor                           3                             1                              2
Hysterectomy after childbearing            50                             14                             36                            0.70
Yes                                         9                               3                            6
No                                         41                             11                              30
Metastasis/recurrence                      50                             14                             36                            0.57
Yes                                        4                              0                              4
No                                         46                             14                             32




              Taiwan J Obstet Gynecol. 2011 Mar;50(1):62-6.
              Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review.
              Chao AS, Chao A, Wang CJ, Lai CH, Wang HS
Analyses of obstetric outcomes according to undergoing:
IVF, ICSI, gamete intrafallopian transfer, or zygote intrafallopian transfer (Group 1)
and spontaneous conception/intrauterine insemination (Group 2)

                                          Group 1 (n=15)                     Group 2 (n=50)                              p

Preterm labor                                 7 (46.7)                         3 (6.0)                                   0.001
Cesarean rate                                 14 (93.3)                       11 (22.0)                                  <0.001
Primigravida                                  14 (93.3)                       36 (72.0) 0.160
Multiple pregnancy                             6 (40.0)                         3 (6.0) 0.003




Taiwan J Obstet Gynecol. 2011 Mar;50(1):62-6.
Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review.
Chao AS, Chao A, Wang CJ, Lai CH, Wang HS
How safe : Endometrial cancer?
n   Numbers are too small to make any
    dogmatic statements.

n   We can preserve fertility

n   After single delivery – most
    recommend hysterectomy.
             Ovarian Cancer
n   Agreed fertility preservation in all young
    patients [?<40 years]- as:

n   1. Germ cell tumours very chemosensitive
n   2. Borderline tumours – normally cured
    with local excision [ if early stage]
n   3. If advanced ovarian cancer – then can
    always re-operate.
n   4. May be another condition – eg Hodgkins
    !!
Invasive Early stage disease
       Schilder et al, Gynecol Oncol, 2002

                         N = 52
     42 stage 1A                          10 stage 1C
     Grade 1 = 35      Grade 2= 9         Grade 3 = 5

                  20 had adjuvant chemotherapy

           5 recurrences [8-78 months after first surgery]
 Sites : Contralateral ovary – 3 , peritoneum 1 and lung 1.

                              2 deaths

            24 attempted pregnancies – 71% conceived.
             Survival at 5 years 98% and 10 years 93%
  Fertility-sparing surgery in young women with mucinous adenocarcinoma
                                  of the ovary.
           Gynecol Oncol. 2011 Aug;122(2):334-8. Kajiyama H et al,Japan

 N=148,The median follow-up time of all mEOC patients was 71.6 (4.8-448.3)
 months




41 patients with Fertility Sparing, 27 = Stage 1a, 14 Stage 1c

5 year overall survival was 97.3%

Compared with 101 women who underwent Radical surgery for the
Same disease – there was no difference in outcome.
       Germ Cell Tumours


Ref            Cases         Chemo Preg             Survival

Perrin 1999    45            29    7 babies         2 deaths

Sagae 2003     26            23    4 pregnancies – no deaths

Zanetta 2001   138           81    40 babies        95% 5 year

For Germ cell tumours – outcome excellent. Most problems
were in the more advanced stage diseases.

Fertility can be retained.
                 Borderline Ovarian Tumours



Ref             Cases       Recurrence        Pregnancies

Gotlieb, 2003   39          8%                22 in 15 women

Zanetta,2001    189         18%               41in 21 women

Demeter, 2002   12          ?                 50%

Donnez,2003     16          18.7%             64%

Boran 2004      62          6.5%              13 in 10 women

Rao , 2005      38          16%               6 in 5 women
            Ovarian Cancer
n   What if Cystectomy performed ?

n   A. If malignant – proceed to
    oophorectomy and full staging

n   B. If borderline – oophorectomy –
    reduces recurrence rates
            Ovarian Cancer
n   Must Monitor the Contra-lateral
    ovary.

n   Ultrasound/tumour markers.
     Borderline Ovarian Cancer
n            Fertility Sparing   Radical     Recurrence


Boran 2005           62           80       6.5% vs 0.0%

Zanetta 2001      189*          150 18.5 % vs 4.6%
• 7 cases progressed to ‘invasive’ carcinoma

Important to counsel the patient and is this evidence to
support routine pelvic clearance after completion of the
family ??
              Ovarian Cancer
n   Fertility conservation safe for Borderline
    tumours.
n   In invasive tumours – probably best to
    restrict fertility preservation surgery to
    properly staged, Stage 1 disease.
n   Following completion of family – pelvic
    clearance seems a logical approach to
    reduce recurrences, and considering the
    limitations of screening such women.
              Conclusions
n   Yes it can be done – but always the
    question is :Should it be done?

n   Need the full Multidisciplinary Team –
    Oncological and Fertility Working
    together. [?Obstetric/Neonatal?]

n   Counsell– Counsell and Counsell
A Healthy Mother and Child

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:2
posted:3/3/2014
language:English
pages:41